All about Rakesh Jhunjhunwala's Portfolio | Top Rakesh Jhunjhunwala holdings

Rakesh Jhunjhunwala Portfolio

by 5paisa Research Team Last Updated: Dec 11, 2022 - 04:14 pm 30.9k Views
Listen icon

Rakesh Jhunjhunwala needs no introduction in the Indian stock markets. His moves and strategies are perhaps the most followed by investors; retail and institutional. He has been given a lot of epithets by the stock market community. To some, Rakesh is the Pied Piper of stock markets, while to some he is the proverbial Big Bull and to many others he is India’s answer to Warren Buffett. 

In a nutshell, there is no gainsaying his immense influence on investors. His portfolio changes are also closely tracked and his profits on Titan and Lupin, by now, are the stuff that legends and stock market folklore are made of. Here is a quick look at his portfolio shifts as of end Mar-22.

As of the close of March 2022, Rakesh Jhunjhunwala held a total of 34 stocks in his family portfolio with a market value of Rs.31,952 crore as of 30th April 2022. Here is a snapshot of his top holdings in rupee value terms.
 

Stock Name

Percentage Holding

Holding Value

Holding Change (QOQ)

Titan Company

5.1%

Rs.11,026 crore

No Change in Holdings

Star Health & Allied Insurance

17.5%

Rs.7,167 crore

No Change in Holdings

Metro Brands Ltd

14.4%

Rs.2,232 crore

No Change in Holdings

Tata Motors

1.2%

Rs.1,718 crore

No Change in Holdings

CRISIL Ltd

5.5%

Rs.1,474 crore

No Change in Holdings

Fortis Healthcare

4.2%

Rs.854 crore

No Change in Holdings

Canara Bank

2.0%

Rs.818 crore

Increased in Q4

Indian Hotels

2.1%

Rs.770 crore

Reduced in Q4

Federal Bank

3.7%

Rs.727 crore

No Change in Holdings

NCC Ltd

12.8%

Rs.537 crore

No Change in Holdings

 

The top-10 stocks account for 85.51% of the value of the portfolio of Rakesh Jhunjhunwala as of end Mar-22. Out of Top-3 holdings, 2 are recent IPOs; Star Health and Metro Brands.


Which stocks did Rakesh Jhunjhunwala add to his portfolio in Q4 FY22?


Let us look at the fresh addition of stocks to his portfolio in the Mar-22 quarter. In the previous Dec-21 quarter, the two big IPOs of Star Health Insurance and Metro Brands entered Rajesh Jhunjhunwala’s top-3 holdings post the IPO.

However, in the Mar-22 quarter, there has been no fresh addition to the portfolio of Rakesh. Obviously, he has kept a low profile amidst a rather volatile and indecisive market in the last quarter.

Let us first look at the stocks where Rakesh Jhunjhunwala increased his holdings in the Mar-22 quarter. There were actually 3 such stocks. He increased his stake in Jubilant Pharmova by 50 basis points from 6.3% holding in the company to 6.8%.
 

banner


The second stock was Canara Bank, where he added to his stake by 40 bps from 1.6% to 2.0% in the Mar-22 quarter. In the Dec-21 quarter, Rakesh had participated in the private placement of shares by Canara Bank. Finally, he also increased his holdings in Indiabulls Housing Finance by 20 bps from 1.1% to 1.3% during the Mar-22 quarter.

In a large number of stocks, his holdings were flat over the previous quarter. However, we would not know the rise or fall in holdings in stocks where the stake was below 1% as such holdings don’t get reported on a quarterly basis.


Which stocks did Rakesh Jhunjhunwala downsize in his portfolio during Q4 FY22?


In the Mar-22 quarter, Rakesh Jhunjhunwala did make a number of reductions in his holdings. Here is a quick look at the stocks where he downsized holdings.

1. The biggest downsizing in the portfolio of Rakesh Jhunjhunwala in the Mar-22 quarter was in Escorts Ltd, where his stake fell from 5.2% to below 1%. However, since stakes below 1% are not reported to the stock exchanges, it is not clear what is his residual holdings now in Escorts.

2. Rakesh Jhunjhunwala has cut his stake in SAIL from 1.1% to below 1% during the Mar-22 quarter. Again, since stakes below 1% are not reported to the stock exchanges, it is not clear what is his residual holdings now in Steel Authority of India Ltd.

3. During the Mar-22 quarter, Rakesh Jhunjhunwala has also cut his stake in TV18 Broadcast Ltd by 30 basis points from 1.5% holding to 1.2% holding.

4. He also downsized his stake in pharma major, Wockhardt Ltd, by 20 bps from 2.3% to 2.1% in the Mar-22 quarter.

5. Finally, there was also a 10 bps reduction in Rakesh Jhunjhunwala’s holdings in Aptech Ltd from 23.4% to 23.3% in the Mar-22 quarter.

Apart from the above, there were several stocks in which there was some offloading of less than 10 bps done, but the selling was not significant to impact his holdings in the stock.

He had sold small quantities during the Mar-22 quarter in stocks like Indian Hotels, Titan Company Ltd, Delta Corp and CRISIL Ltd.

Overall, the stocks like Star Health Insurance, Metro Brands and Fortis Healthcare contributed a good deal in Rakesh Jhunjhunwala witnessing capital losses in the Mar-22 quarter vis-à-vis the Dec-21 quarter.


How did Rakesh Jhunjhunwala portfolio perform this year?


How did the portfolio of Rakesh Jhunjhunwala perform as of the end of March 2022 quarter compared to different time frames in the past.

Interestingly, the portfolio of Rakesh Jhunjhunwala virtually did not make any returns between September 2015 and March 2020, when the markets bottomed out after the pandemic. The real story started after that.

Between Mar-20 and Sep-21, the portfolio value went up from Rs.8,356 crore to Rs24,235 crore. That is a 2.9 fold appreciation. Let us look at two time frames; from the lows of March 2020 and over the last one year.

1) Over the last 1 year period i.e. between March 2021 and March 2022, the portfolio value of Rakesh Jhunjhunwala appreciated from Rs.16,727 crore to Rs.31,952 crore. That is an annualized return of 91%.

However, if you remove the approximately Rs.10,000 crore of value added by the two IPOs of Star Health Insurance and Metro Brands, the portfolio performance would be more modest.

2) Over the last 2 year period i.e. between March 2020 and March 2022, the portfolio value of Rakesh Jhunjhunwala appreciated from Rs.8,356 crore to Rs.31,952 crore. That is an annualized CAGR return of 95.5%.

However, once again if you remove the Rs.10,000 crore of value added by the two IPOs of Star Health Insurance and Metro Brands, the portfolio performance would be more modest.

One thing is clear that most of the returns on the Rakesh Jhunjhunwala portfolio have come in the 6 quarters between Mar20 and Sep-21. In the last 2 quarters, the performance has been tepid to negative.

Also Read:-

Vijay Kedia Portfolio: March 2022

Radhakishan Damani Portfolio: March 2022

How do you rate this blog?

Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

oda_gif_reasons_colorful

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Open Free Demat Account
Resend OTP
Please Enter OTP
Mobile No. belongs to

By proceeding, you agree to the T&C.

Latest Blogs
Top Private Banks in India 2024

India has a large banking sector with 21 private and 12 public sector banks. The top private banks in India are the reason behind India’s economic growth, making it one of the most rapidly emerging nations in the world. Moreover, with becoming the most populated country around the globe, India also has the largest economy. 

Mukka Proteins IPO Allotment Status

About the Mukka Proteins Ltd IPO The stock of Mukka Proteins Ltd has a face value of ₹1 per share and the price band for the book building IPO has been set in the range of ₹26 to ₹28 per share. The Mukka Proteins IPO will be entirely a fresh issue of shares with no offer for sale (OFS) component. A fresh issue tends to bring in fresh funds into the company, but is also EPS and equity dilutive.

M.V.K. Agro Food Product IPO Allotment Status

Building blocks of the M.V.K. Agro Food Product Ltd IPO The stock of M.V.K. Agro Food Product Ltd has a face value of ₹10 per share and it is a fixed price issue. The price for the book building issue is set at ₹120 per share. Being a fixed price IPO, the question of price discovery does not arise in this case. The M.V.K.